Results 71 to 80 of about 14,860 (180)

Helping Smokers Quit: State Cessation Coverage [PDF]

, 2008
Analyzes state health insurance coverage for treatments to quit smoking and how coverage through state Medicaid, state employee health plans, private insurance, and "quitlines" saves states healthcare costs.

core  

Evaluation of the cardiovascular effects of varenicline in rats

Drug Design, Development and Therapy, 2015
Engin Burak Selçuk,1 Meltem Sungu,2 Hakan Parlakpinar,3 Necip Ermiş,4 Elif Taslıdere,5 Nigar Vardı,5 Murat Yalçinsoy,6 Mustafa Sagır,3 Alaaddin Polat,7 Mehmet Karatas,8 Burcu Kayhan-Tetik11Department of Family Medicine, 2Inonu University ...
Selçuk EB, Sungu M, Parlakpinar H, Ermiş N, Taslıdere E, Vardı N, Yalçınsoy M, Sagır M, Polat A, Karatas M, Kayhan-Tetik B   +10 more
doaj  

Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat

Frontiers in Behavioral Neuroscience, 2019
Nicotine is acknowledged as the key addictive compound of tobacco. Varenicline (Champix® or Chantix®), mainly acting as a partial agonist at the α4β2 nicotinic receptor, is an approved smoking cessation pharmacotherapy, although with efficacy limited to ...
Vernon Garcia-Rivas, Vernon Garcia-Rivas, Jean-François Fiancette, Jean-François Fiancette, Nazzareno Cannella, Nazzareno Cannella, Maria Carbo-Gas, Maria Carbo-Gas, Prisca Renault, Prisca Renault, Jessica Tostain, Jessica Tostain, Véronique Deroche-Gamonet, Véronique Deroche-Gamonet   +13 more
doaj   +1 more source

The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence [PDF]

BACKGROUND: Tobacco smoking is the cause of many preventable diseases and premature deaths in the UK and around the world. It poses enormous health- and non-health-related costs to the affected individuals, employers, and the society at large.
Brown, AK, Ekpu, VU
core   +1 more source

The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. [PDF]

, 2012
BACKGROUND: The txt2stop trial has shown that mobile-phone-based smoking cessation support doubles biochemically validated quitting at 6 months. This study examines the cost-effectiveness of smoking cessation support delivered by mobile phone text ...
Cairns, John, Free, Caroline, Guerriero, Carla, Roberts, Ian, Rodgers, Anthony, Whittaker, Robyn   +5 more
core   +2 more sources

Physical multimorbidity and quit outcomes in a publicly funded smoking cessation programme

Internal Medicine Journal, Volume 56, Issue 3, Page 410-416, March 2026.
Abstract Objectives To examine the association between physical multimorbidity and 6‐month quit outcomes among treatment‐seeking smokers. Methods We analysed data from 120 732 adults enrolled in Ontario's largest publicly funded smoking cessation programme.
Polina Kyrychenko, Benjamin K. C. Wong, Scott Veldhuizen, Nadia Minian, Laurie Zawertailo, Peter Selby, Osnat C. Melamed   +6 more
wiley   +1 more source

Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism [PDF]

, 2016
Background This study examined whether varenicline (VAR), or naltrexone (NTX), alone or in combination, reduces alcohol drinking in alcohol-preferring (P) rats with a genetic predisposition toward high voluntary alcohol intake.
Dilley, Julian E., Filosa, Nick, Fischer, Stephen M., Froehlich, Janice C., Nicholson, Emily, Rademacher, Logan, Smith, Teal   +6 more
core   +4 more sources

Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder

Journal of Internal Medicine, Volume 299, Issue 3, Page 302-327, March 2026.
Abstract Gene therapy is emerging as a groundbreaking strategy for treating epilepsy, offering new hope to patients who do not respond to conventional medications. Despite advancements in anti‐seizure treatments, nearly 30%–40% of individuals with epilepsy continue to experience uncontrolled seizures, highlighting the urgent need for more effective and
Marco Ledri, Merab Kokaia
wiley   +1 more source

Beyond the Ocular Surface: Nasal Sensory Input as a Driver of Reflex Lacrimation in Dogs

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Objective To evaluate the effect of nasal mucosal anesthesia on aqueous tear secretion in dogs and to compare responses between brachycephalic and non‐brachycephalic breeds. Animal Studied Twenty healthy dogs (10 Australian Shepherds, 10 Boston Terriers). Procedures All dogs received 0.5 mL of 10% lidocaine or saline into one randomly selected
Shelley W. Cochran, Nick J. Millichamp, Lionel Sebbag   +2 more
wiley   +1 more source

Nicotine dependence and neuropsychotic effects of varenicline

Безопасность и риск фармакотерапии, 2018
Varenicline is a partial agonist of nicotinic acetylcholine receptors for the therapy of nicotine addiction. The efficacy and safety of the use of varenicline in the treatment of nicotine dependence have been demonstrated in clinical trial EAGLES.
T. M. Bukatina, A. S. Kazakov, R. N. Alyautdin, T. V. Romanova, I. I. Snegireva   +4 more
doaj   +1 more source